ALLERGY THERAPEUTICS PLC
Immunology company developing aluminum-free vaccines and therapies for allergies.
AGY | IL
Overview
Corporate Details
- ISIN(s):
- GB00B02LCQ05
- LEI:
- 213800PQ7AHK7KGVOE23
- Country:
- United Kingdom
- Address:
- DOMINION WAY, BN14 8SA WORTHING
- Website:
- https://allergytherapeutics.com/
- Sector:
- Manufacturing
Description
Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-01 08:00 |
Update on funding and preliminary results
|
English | 11.7 KB | ||
| 2024-09-17 08:00 |
Progression of patient cohorts in PROTECT Trial
|
English | 17.0 KB | ||
| 2024-08-27 08:00 |
Update on funding
|
English | 12.0 KB | ||
| 2024-07-22 08:01 |
Trading update for the year ended 30 June 2024
|
English | 20.8 KB | ||
| 2024-07-22 08:00 |
Appointment of Nominated Adviser and Sole Broker
|
English | 9.2 KB | ||
| 2024-07-04 15:22 |
Launch of new Company Long Term Incentive Plan
|
English | 25.9 KB | ||
| 2024-06-27 08:00 |
Appointment of Non-Executive Director
|
English | 12.5 KB | ||
| 2024-06-10 08:00 |
Progression of patient cohorts in PROTECT Trial
|
English | 15.7 KB | ||
| 2024-06-03 08:00 |
Successful meetings with Paul Ehrlich Institut
|
English | 16.9 KB | ||
| 2024-05-31 08:00 |
Allergy Therapeutics presents findings at EAACI
|
English | 21.6 KB | ||
| 2024-05-07 08:00 |
Further detail from G306 Phase III field trial
|
English | 20.4 KB | ||
| 2024-04-03 08:00 |
Director Resignation
|
English | 9.9 KB | ||
| 2024-03-27 08:00 |
Interim Results for six months ended 31 Dec 2023
|
English | 210.5 KB | ||
| 2024-03-27 08:00 |
Update on funding
|
English | 13.2 KB | ||
| 2024-03-12 09:59 |
VLP Peanut PROTECT Trial Update
|
English | 15.9 KB |
Automate Your Workflow. Get a real-time feed of all ALLERGY THERAPEUTICS PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ALLERGY THERAPEUTICS PLC
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ALLERGY THERAPEUTICS PLC via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
